業績集‎ > ‎

2009

1. Casellas R, Yamane A, Kovalchuk AL, Potter M.Restricting activation-induced cytidine deaminase tumorigenic activity in B lymphocytes.Immunology. 126:316-328, 2009. 

2. Doki N, Kawashima T, Nomura Y, Tsuchiya A, Oneyama C, Akagi T, Nojima Y, Kitamura T.Constitutive phosphorylation of a Rac GAP MgcRacGAP is implicated in v-Src-induced transformation of NIH3T3 cells. Cancer Sci. 100:1675-1679, 2009.

3. Fujita H, Yoshida M, Miura K, Sano T, Kito K, Takahashi M, Shigeno K, Kanda Y, Akiyama N, Hatsumi N, Ohnishi K, Miyawaki S, Naoe T. Management of infection in patients with acute leukemia during chemotherapy in Japan: questionnaire analysis by the Japan Adult Leukemia Study Group. Int J Hematol. 90:191-198, 2009. 

4. Hamdi W, Ogawara H, Handa H, Tsukamoto N, Nojima Y, Murakami H. Clinical significance of regulatory T cells in patients with myelodysplastic syndrome. Eur J Haematol. 82:201-207, 2009.

5. Hashimoto Y, Tsukamoto N, Nakahashi H, Yokohama A, Saitoh T, Handa H, Matsushima T, Murakami H, Nojima Y, Karasawa M. Hairy cell leukemia-related disorders consistently show low CD27 expression. Pathol Oncol Res 15:615-621, 2009. 

6. Ishikawa Y, Kiyoi H, Tsujimura A, Miyawaki S, Miyazaki Y, Kuriyama K, Tomonaga M, Naoe T.Comprehensive analysis of cooperative gene mutations between class I and class II in de novo acute myeloid leukemia. Eur J Haematol. 83:90-98, 2009.
7. Isoda A, Ogawa Y, Matsumoto M, Sawamura M. Coexistence of paroxysmal nocturnal hemoglobinuria (PNH) and acute lymphoblastic leukemia (ALL): Is PNH a prodrome of ALL? Leuk Res 33:3-5, 2009. 
8. Isoda A, Sakurai A, Ogawa Y, Miyazawa Y, Saito A, Matsumoto M, Sawamura M. Chronic inflammatory demyelinating polyneuropathy accompanied by chronic myelomonocytic leukemia: possible pathogenesis of autoimmunity in myelodysplastic syndrome. Int J Hematol 90:239-242, 2009. 
9. Kato,M, Noda,M, Suga, H, Matsumoto, M, Kanazawa,Y, and the Omiya Medical Association Cohort Study Group Fasting plasma glucose and icidence of diabetes---Implication for the threshold for impaired glucose: Results from the population-based Omiya MA Cohort Study :J Atheroscler Thromb, 16: 857-861, 2009. 

10. Kobayashi Y, Tobinai K, Takeshita A, Naito K, Asai O, Dobashi N, Furusawa S, Saito K, Mitani K, Morishima Y, Ogura M, Yoshiba F, Hotta T, Bessho M, Matsuda S, Takeuchi J, Miyawaki S, Naoe T, Usui N, Ohno R. Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia: final results of Japanese multicenter cooperative study. Int J Hematol.89:460-469, 2009.
11. Kodama T, Abe M, Iida S, Ozaki S, Sakai A, Sawamura M, Shimazaki C, Miyata A, Wakayama T, Murakami H. A pharmacokinetic study evaluating the relationship between treatment efficacy and incidence of adverse events with thalidomide plasma concentrations in patients with refractory multiple myeloma. Clin Lymphoma Myeloma 9:154-159, 2009. 
12. Kojima M, Sakurai S, Isoda A, Tsukamoto N, Masawa N, Nakamura N. Follicular lymphoma resembling with Hyalinevascular type of Castleman’s disease. The morphological and immunohistochemical findings of two cases. Case Report. Cancer Therapy 7:109-112, 2009. 
13. Kojima M, Tsukamoto N, Yokohama A, Suzuki Y, Shimizu K, Nishikawa M, Murayama K, Miyanaga T, Isoda A, Shimizu K, Itoh H, Masawa N, Yoshida K, Inagaki H. B-cell lymphoma associated with Sjögren's syndrome among Japanese patients: a clinicopathologic and immunohistochemical study of 15 cases. J Clin Exp Hematop 49:89-95, 2009. 
14. Kojima M, Motoori T, Tamaki Y, Igarashi T, Matsumoto M, Shimizu K, Ogawa A, Itoh H, Asano S, Masawa N, Inagaki H. Cyclin D1 protein overexpression in extramedullary plasmacytoma: a clinicopathologic study of 11 cases. J Clin Exp Hematop 49:53-56, 2009.
15.
Murakami H, Shimizu K, Sawamura M, Suzuki K, Sugiura I, Kosugi H, Shimazaki C, Taniwaki M, Abe M, Takagi T. Phase II and pharmacokinetic study of thalidomide in Japanese patients with relapsed/refractory multiple myeloma. Int J Hematol 89(5):636-641, 2009. 

16. Nakahashi H, Tsukamoto N, Yamane A, Saitoh T, Uchiumi H, Handa H, Karasawa M, Murakami H, Kojima M, Nojima Y. Autologous peripheral blood stem cell transplantation to treat CHOP-refractory aggressive subcutaneous panniculitis-like T cell lymphoma. Acta Haematol 121(4):239-242, 2009. 

Nakahashi H, Tsukamoto N, Hashimoto Y, Koiso H, Yokohama A, Saitoh T, Uchiumi H, Handa H, Murakami H, Nojima Y, Karasawa M. Characterization of immunoglobulin heavy and light chain gene expression in chronic lymphocytic leukemia and related disorders. Cancer Sci 100(4):671-677, 2009. 

17. Naoe T, Usui N, Ohno R. Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia: final results of Japanese multicenter cooperative study. Int J Hematol. 89:460-469, 2009 

18. Okada Y, Nakamura K, Hiromura K, Nojima Y, Horiuchi R, Yamamoto K: Pro32Thr Polymorphism of Inosine Triphosphate Pyrophosphatase Gene Predicts Efficacy of Low-Dose Azathioprine for Patients With Systemic Lupus Erythematosus. Clin Pharmacol Ther. 85:527-530, 2009

19. Sakamaki H, Ishizawa K, Taniwaki M, Fujisawa S, Morishima Y, Tobinai K, Okada M, Ando K, Usui N, Miyawaki S, Utsunomiya A, Uoshima N, Nagai T, Naoe T, Motoji T, Jinnai I, Tanimoto M, Miyazaki Y, Ohnishi K, Iida S, Okamoto S, Seriu T, Ohno R. Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia.Int J Hematol. 89:332-41, 2009. 

20. Sakurai N, Kuroiwa T, Ikeuchi H, Hiramatsu N, Takeuchi S, Tomioka M, Shigehara T, Maeshima A, Kaneko Y, Hiromura K, Kopp JB, Nojima Y: Fluvastatin prevents podocyte injury in a murine model of HIV-associated nephropathy. Nephrol Dial Transplant. 24:2378-2383, 2009

21. Shimizu N, Tanaka A, Oue A, Mori T, Ohtsuki T, Apichartpiyakul C, Uchiumi H, Nojima Y, Hoshino H. Broad usage spectrum of G protein-coupled receptors as coreceptors by primary isolates of HIV. AIDS. 23:761-769, 2009


22. Sunami K, Shinagawa K, Sawamura M, Sakai A, Saburi Y, Imamura Y, Mizuno I, Tamaki S, Kamimura T, Tsuda H, Gondo H, Hino N, Shimazaki C, Miyata A, Tajima F, Takemoto Y, Miwa A, Chou T, Harada M. Phase I/II study of tandem high-dose chemotherapy with autologous peripheral blood stem cell transplantation for advanced multiple myeloma. Int J Hematol 90(5):635-642, 2009.
23. Tanaka M, Kano Y, Akutsu M, Tsunoda S, Izumi T, Yazawa Y, Miyawaki S, Mano H, Furukawa Y.The cytotoxic effects of gemtuzumab ozogamicin (mylotarg) in combination with conventional antileukemic agents by isobologram analysis in vitro. Anticancer Res. 29:4589-96, 2009.

24. Toyama K, Karasawa M, Yamane A, Koiso H, Yokohama A, Uchiumi H, Saitoh T, Handa H, Sato K, Takagi H, Miyawaki S, Murakami H, Nojima Y, Tsukamoto N.  Low burden of a JAK2-V617F mutated clone in monoclonal haematopoiesis in a Japanese woman with Budd-Chiari syndrome. Int J Hematol. 89:517-522, 2009.

25. Yamamoto T, Carrero JJ, Lindholm B, Stenvinkel P, Axelsson J. Leptin and uremic protein-energy wasting--the axis of eating. Semin Dial. 22:387-390, 2009.

26. Yamane A, Tsukamoto N, Saitoh T, Uchiumi H, Handa H, Karasawa M, Nojima Y, Murakami H. Successful treatment by all-trans retinoic acid in a patient with acute promyelocytic leukemia complicated by liver cirrhosis and polycystic kidney.Intern Med. 48:1691-1694, 2009.

27. Yu J, Ershler M, Yu L, Wei M, Hackanson B, Yokohama A, Mitsui T, Liu C, Mao H, Liu S, Liu Z, Trotta R, Liu CG, Liu X, Huang K, VisserJ, Marcucci G, Plass C, Belyavsky AV, Caligiuri MA. TSC-22 contributes to hematopoietic precursor cell proliferation and repopulation and is
epigenetically silenced in large granular lymphocyte leukemia. Blood. 113: 5558-5567, 2009

1.
石川裕一、清井仁, 辻村朱音, 宮崎泰司, 朝長万左男, 栗山一孝, 宮脇修一, 直江知樹 WHO分類に基づく急性骨髄性白血病における網羅的遺伝子変異の解析 臨床血液(0485-1439)50巻8号 Page597-603(2009.08) 
2. 小磯 博美, 田原研一, 大崎 洋平, 馬渡 桃子, 関上 智美, 横濱 章彦, 斉藤 貴之, 内海 英貴, 半田 寛, 塚本 憲史, 唐沢 正光, 野島 美久, 村上 博和. Bortezomib治療中にM蛋白が消失したにもかかわらず髄外形質細胞腫が出現した多発性骨髄腫. 臨床血液 50: 78-82, 2009.

3. 小磯博美、小林さつき、植木嘉衛、濱田哲也、塚本憲史、唐沢正光、村上博和、野島美久. 
A型ウィルス肝炎経過中に自己免疫性溶血性貧血に伴って発症した赤芽球癆. 臨床血液 2009, 50, 424-429.

4. 小磯博美、横浜章彦、塚本憲史、村上博和. Picture in Clinical Hematology-花弁様の核を認めた多発性骨髄腫. 臨床血液 2009, 37, 337.

5. 高田覚、宮脇修一 急性白血病とQOL 血液フロンティア vol.19,No.1,2009, p35-p43 

6. 田原研一, 横濱章彦, 半田寛, 斉藤貴之, 内海英貴, 関上智美, 外山耕太郎, 馬渡桃子, 大崎洋平, 松島孝文, 唐沢正光,村上博和, 塚本憲史, 野島美久. RISTが有効であった真性多血症からの二次性骨髄線維症. 臨床血液. 50: 1630-1634,2009

7. 日下田大輔, 横濱章彦, 大崎洋平, 田原研一, 馬渡桃子, 関上智美, 小磯博美, 斉藤貴之, 内海英貴, 半田寛, 唐沢正光,村上博和, 平戸純子, 塚本憲史, 野島美久. 全身性アミロイドーシスとして発症したIgM-λ型多発性骨髄腫. 臨床血液. 50:1711-1714, 2009

8. 廣村桂樹:免疫抑制療法と免疫療法 薬の上手な使い方 腎炎、腎症の免疫抑制療法 シクロホスファミド 腎と透析 66:950-952, 2009

9. 前嶋明人 Basic Nephrology 尿細管再生に関する最近の知見 Annual Review腎臓2009巻 Page43-49

10. 宮脇恒太, 宮脇修一 【Emergency 実戦ガイド】疾患と対応 血液 急性白血病(解説/特集) 内科(0022-1961)103巻6号 Page1596-1601(2009.06) 

11. 宮脇修一 予後中間群の急性骨髄性白血病に幹細胞移植を適応とする因子(解説) Trends in Hematological Malignancies(1883-9053)1巻1号 Page26-28(2009.07) 

12. 宮脇修一【治療方針決定に苦慮する造血器腫瘍に対する治療指針】 治療抵抗・再発急性骨髄性白血病の治療(解説/特集) 血液・腫瘍科(0915-8529)58巻4号 Page381-388(2009.04) 

13. 半田寛、村上博和. EBM血液疾患の治療2010-2011 形質細胞性白血病に対する治療は? 中外医学社pp398-405.

14. 半田寛、村上博和.ビスフォスフォネートとONJ~素因としてのCYP2C8多型との関連~
15. 血液フロンティア2009, 19(12), 1962-1967.

16. 村上博和、半田寛、斉藤貴之、小河原はつ江.最新医学.多発性骨髄腫-最近の進歩―多発性骨髄腫の治療:総論. 2009, 64(12), 2525-2533. 最新医学社.

17. 村上博和、半田寛、斉藤貴之. がん診療update. Ⅱ.各論. 12)造血器. 多発性骨髄腫. 日本医師会雑誌 特別号(1) 2009, 138, 300-302.

18. 村上博和、小河原はつ江、半田寛. WHO分類第4版による白血病・リンパ系腫瘍の病態学. 10.成熟B細胞腫瘍. 7)重鎖病. 中外医学社pp214-220.

19. 村上博和、小河原はつ江、半田寛. WHO分類第4版による白血病・リンパ系腫瘍の病態学. 10.成熟B細胞腫瘍. 8)形質細胞腫瘍. 中外医学社pp220-250.

20. 村上博和 特集・新時代の骨髄腫治療 7.サリドマイド治療の実際~TERMS 遵守と副作用マネージメント~。血液フロンティア 2009, 19, 1245~1253

21. 村上博和. 「長期生存も可能になってきた多発性骨髄腫の治療」別冊がんサポート-血液がん 2009, 75, 80-85.

22. 村上博和 特集 「サリドマイド製剤安全管理手順TERMSを知る」 -TERMSを実行する医師の立場から-日本骨髄腫患者の会会報誌 がんばりまっしょい 9号、pp16-17, 2009.

23. 和田英夫、朝倉英策、岡嶋研二、丸藤 哲、射場敏明、内場光浩、内山俊正、江口豊、岡本好司、小倉真治、川杉和夫、久志本成樹、小池薫、古賀震、関義信、窓岩清治、真弓俊彦)日本血栓止血学会学術標準化委員会DIC部会(丸山征郎、坂田洋一、科学的根拠に基づいた感染症に伴うDIC治療のエキスパートコンセンサス血栓止血誌 20(1): 77-113、2009




Comments